Expect heavy selling pressure as the market digests this massive dilutive offering. Monitor the stock for after-market trading; the offering effectively doubles the share count and signals significant cash burn. Avoid buying into weakness until the stock stabilizes post-offering.
Price Chart
Executive Summary
Artiva Biotherapeutics priced a $300M underwritten public offering of 23.9M shares and pre-funded warrants for 2.2M shares at $11.52 per share, equating to roughly 100% dilution of existing shares. The massive capital raise signals urgent cash needs for a pre-revenue biotech and will severely dilute existing shareholders.
Key Facts
- Offering of 23,871,526 shares and 2,170,138 pre-funded warrants for common stock
- Price: $11.52 per share; $11.5199 per pre-funded warrant
- Gross proceeds approximately $300 million
- Closing expected May 11, 2026
- Dilution of ~50% to ~100% relative to pre-offering share count
Financial Impact
Approximately $300 million gross proceeds, representing ~50-100% dilution of existing equity based on pre-offering market cap of ~$309 million
Risk Factors
- Extreme dilution to existing shareholders
- Potential for further capital raises if cash burn continues
- Downward pressure on stock price as new shares enter the market
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-214711 |
| Document: d20969dex41.htm | 0001193125-26-214711 |
| Document: d20969d8k.htm | 0001193125-26-214711 |
| Document: d20969dex51.htm | 0001193125-26-214711 |
| Document: 0001193125-26-214711-index-headers.html | 0001193125-26-214711 |
| Document: 0001193125-26-214711-index.html | 0001193125-26-214711 |
| Document: 0001193125-26-214711.txt | 0001193125-26-214711 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 11, 2026 20d ago | 8-K | $10.14 $8.91 | ▼ −12.13% | ▼ −11.67% | $6.86 (−32.35%) |
Sep 9, 2026 23d ago | Insider Cluster | $10.79 $10.42 | ▼ −3.43% | ▼ −2.83% | $6.86 (−36.42%) |
Sep 9, 2026 23d ago | Insider Cluster | $10.79 $10.42 | ▼ −3.43% | ▼ −2.83% | $6.86 (−36.42%) |
Sep 9, 2026 23d ago | Insider Cluster | $10.79 $10.42 | ▼ −3.43% | ▼ −2.83% | $6.86 (−36.42%) |
Sep 9, 2026 23d ago | Insider Cluster | $10.79 $10.42 | ▼ −3.43% | ▼ −2.83% | $6.86 (−36.42%) |
Sep 9, 2026 23d ago | Insider Cluster | $10.79 $10.42 | ▲ +3.43% | ▲ +2.83% | $6.86 (+36.42%) |
Sep 4, 2026 28d ago | Insider Cluster | $11.19 $10.88 | ▼ −2.77% | ▼ −2.22% | $6.86 (−38.70%) |
Aug 15, 2026 6w ago | Institutional Cluster | $11.74 $11.68 | ▼ −0.51% | ▲ +0.16% | $6.86 (−41.57%) |
Jul 31, 2026 8w ago | Insider Buy | $10.76 $11.07 | ▲ +2.88% | ▲ +1.08% | $6.86 (−36.25%) |
Jul 28, 2026 9w ago | Insider Buy | $10.53 $10.02 | ▼ −4.84% | ▼ −3.30% | $6.86 (−34.85%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access